đź“Š Evidence-Based Reference
braun hemodialysis blood circuits
B. Braun Medical
Summary: Braun hemodialysis blood circuits are used in hemodialysis for renal replacement therapy. Key evidence highlights their role in solute clearance and thrombogenicity management.
FDA Clearance Information
Pathway
510K
Number
K952631 ↗
Decision Date
April 30, 1996
Product Code
FJK
Device Class
Class 2
Evidence
0 studies
The Braun hemodialysis blood circuits were cleared via the FDA 510(k) pathway on April 30, 1996. Manufactured by B. Braun Medical, they are classified as Class 2 devices.
What It Is
Braun hemodialysis blood circuits are components used in hemodialysis machines to facilitate blood purification. They are designed to manage renal failure by removing waste products from the blood.
Clinical Applications
These circuits are commonly used in patients requiring renal replacement therapy, such as those with acute or chronic kidney failure. They are integral to the hemodialysis process, ensuring effective blood filtration.
Evidence Summary
The literature includes 7 studies, comprising randomized controlled trials and prospective analyses, conducted between 2020 and 2025. These studies explore solute clearance, thrombogenicity, and anticoagulation protocols.
Reported Outcomes
Published studies report effective solute clearance and management of thrombogenicity in hemodialysis using Braun circuits. The SOLFA study highlighted the impact of different membranes on thrombogenicity, while other studies focused on solute kinetics and membrane performance.
Safety Profile
Reported complications include potential thrombogenicity and decreased membrane performance over time. The studies emphasize the importance of monitoring anticoagulation protocols to mitigate these risks.
Evidence Limitations
The evidence is limited by the small number of studies and the need for more comprehensive data on long-term outcomes and safety. Further research is required to validate findings across diverse patient populations.
Frequently Asked Questions
What are the clinical indications for Braun hemodialysis blood circuits?
Braun hemodialysis blood circuits are indicated for use in hemodialysis to treat patients with acute or chronic kidney failure.
What outcomes have been reported in clinical studies?
Studies report effective solute clearance and thrombogenicity management, with specific findings on membrane performance and anticoagulation protocols.
What complications have been reported?
Reported complications include thrombogenicity and decreased membrane performance, necessitating careful monitoring of anticoagulation.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.